Edition:
India

Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

10.09USD
1:32am IST
Change (% chg)

$0.11 (+1.10%)
Prev Close
$9.98
Open
$9.91
Day's High
$10.15
Day's Low
$9.81
Volume
45,282
Avg. Vol
61,672
52-wk High
$12.04
52-wk Low
$5.80

Chart for

About

Enzo Biochem, Inc. is a bioscience company focusing on delivering and applying technology capabilities to produce products and services. The Company's segments include Enzo Clinical Labs, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Labs is a clinical reference laboratory providing a range of clinical services to... (more)

Overall

Beta: 0.85
Market Cap(Mil.): $485.96
Shares Outstanding(Mil.): 46.55
Dividend: --
Yield (%): --

Financials

BRIEF-‍Enzo Biochem announces NYS department of health's approval of a new women's health infectious disease panel​

* ‍Enzo Biochem announces NYS department of health's approval of a new women's health infectious disease panel​ Source text for Eikon: Further company coverage:

23 Oct 2017

CORRECTED-BRIEF-Enzo Biochem Q4 non-gaap net income of $0.00 per share (Sept 27)

(Corrects headline and third bullet to Q4 non-gaap net income of $0.00/share from non-gaap loss of $0.04/share) Enzo Biochem Inc:

28 Sep 2017

BRIEF-Enzo Biochem files for mixed shelf of up to $150 million ‍​

* Files for mixed shelf of up to $150 million - SEC filing ‍​ Source text for Eikon: Further company coverage:

02 Sep 2017

BRIEF-Enzo Biochem says federal judge in a U.S. Court has entered an order in action entitled Enzo Life Sciences v. Abbott Laboratories ​

* Enzo Biochem says ‍a federal judge in a U.S. Court has entered an order in action entitled Enzo Life Sciences, Inc. v. Abbott Laboratories - sec filing​

16 Aug 2017

BRIEF-Enzo Biochem announces NY state health department approval of New Women’S Health Diagnostics

* Enzo Biochem announces New York State Health Department approval of new Women’s Health Diagnostics

09 Jun 2017

Earnings vs. Estimates